Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

V. Calvo · SciRah

Researcher profile · Semantic Scholar

V. Calvo

Share profile

V. Calvo — researcher profile on SciRah

h-index: 8
Works: 51
Citations: 170

Most-cited papers

Analysis of circulating tumour DNA to identify patients with epidermal growth factor receptor-positive non-small cell lung cancer who might benefit from sequential tyrosine kinase inhibitor treatment.
M. Provencio, R. Serna-Blasco, Fabio Franco, V. Calvo +24 more
2021European Journal of Cancer31 citations Open access
Semantic Scholar
PL03.12 Progression Free Survival and Overall Survival in NADIM II Study
M. Provencio, R. Serna, E. Nadal, J. L. Glez Larriba +23 more
2022Journal of Thoracic Oncology27 citations Open access
Semantic Scholar
Dynamic circulating tumor DNA quantificaton for the individualization of non-small-cell lung cancer patients treatment
M. Provencio, M. Torrente, V. Calvo, L. Gutiérrez +10 more
2017OncoTarget25 citations Open access
Semantic Scholar
OA12.05 APOLO: Phase II Trial of Induction Chemo-Immunotherapy Plus Chemoradiotherapy and Maintenance Immunotherapy in Stage III NSCLC
M. Provencio, B. Campos, M. Guirado, L. Vila +23 more
2024Journal of Thoracic Oncology21 citations Open access
Semantic Scholar
OA20.02 Pre-Treatment Levels of ctDNA for Long-Term Survival Prediction in Stage IIIA NSCLC Treated With Neoadjuvant Chemo-Immunotherapy
A. Romero, E. Nadal, R. Serna, A. Insa +23 more
2021Journal of Thoracic Oncology21 citations Open access
Semantic Scholar
OA20.01 Long Term Survival in Operable Stage Iiia Nsclc Patients Treated With Neoadjuvant Nivolumab Plus Chemotherapy - Nadim Study
M. Provencio, E. Nadal, A. Insa, M. Garcia Campelo +24 more
2021Journal of Thoracic Oncology11 citations Open access
Semantic Scholar
OA01.05 Phase II Study of Neo-Adjuvant Chemo/Immunotherapy for Resectable Stages IIIA Non-Small Cell Lung Cancer- Nadim Study-SLCG
M. Provencio, E. Nadal, A. Insa, R. Campelo +14 more
2018Journal of Thoracic Oncology10 citations Open access
Semantic Scholar
KRAS p.G12C mutation occurs in 1% of EGFR-mutated advanced non-small-cell lung cancer patients progressing on a first-line treatment with a tyrosine kinase inhibitor
R. Serna-Blasco, E. Sánchez-Herrero, S. Sanz-Moreno, A. Rodríguez-Festa +11 more
2021ESMO Open9 citations Open access
Semantic Scholar
PL03.10 Adjuvant Chemotherapy (CT) vs CT-immunotherapy for R0 Stage IB-IIIA NSCLC Patients (NADIM ADJUVANT): a Randomized, Phase 3 Trial
M. Provencio, R. Bernabe, E. Nadal, A. Martínez-Martí +26 more
2025Journal of Thoracic Oncology3 citations Open access
Semantic Scholar
MA01.08 Five-Year Clinical Outcomes of Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer (NADIM Trial)
M. Provencio, E. Nadal, A. Insa, M. Garcia Campelo +16 more
2024Journal of Thoracic Oncology3 citations
Semantic Scholar
MA06.03 Pre-treatment ctDNA Levels Significantly Predicts of OS and PFS in NADIM II Trial
A. Romero, R. Serna, E. Nadal, J. L. Glez Larriba +24 more
2022Journal of Thoracic Oncology3 citations Open access
Semantic Scholar
P31.03 The Impact of the COVID-19 Pandemic on a Thoracic Tumor Unit of a Tertiary Hospital in Spain
L. Cudero, V. Calvo, Y. Garitaonaindia, A. Collazo-Lorduy +5 more
2021Journal of Thoracic Oncology3 citations Open access
Semantic Scholar
MA01.03 Metabolomic Analysis Identifies Histamine as a Key Predictive Factor for Perioperative Chemoimmunotherapy in NADIM II Trial
P. Mediavilla-Medel, E. Nadal, J. González-Larriba, A. Martínez-Martí +26 more
2025Journal of Thoracic Oncology1 citations Open access
Semantic Scholar
187P Tissue B-cell receptor repertoire as biomarker of complete pathological response in NSCLC patients treated with neoadjuvant chemoimmunotherapy (NADIM trials)
B. Sierra-Rodero, C. Martínez-Toledo, M. Molina-Alejandre, V. Calvo +16 more
2023Journal of Thoracic Oncology1 citations Open access
Semantic Scholar
P54.04 Detecting Elevated Risk of Diminished Quality of Life Among Lung Cancer Patients by Using Wearable Devices
M. Torrente, F. Franco, A. C. Lorduy, V. Calvo +18 more
2021Journal of Thoracic Oncology1 citations Open access
Semantic Scholar
P3.130: Microbiome Functional Signatures as Potential Biomarkers and Mechanistic Modulators of Response to Neoadjuvant Therapy in NSCLC
R. Serna-Blasco, A. S. M. Doblado, A. Rodríguez-Festa, E. Nadal +25 more
2026Journal of Thoracic Oncology0 citations
Semantic Scholar
MO06.09: Role of PET/CT in the Neoadjuvant Chemoimmunotherapy Approach for Resectable NSCLC: Results From the NADIM II and REAL-NADIM Trials
R. Jimeno, A. Ospina, V. Calvo, E. Nadal +16 more
2026Journal of Thoracic Oncology0 citations
Semantic Scholar
P3.173: Gut Microbiome Taxa Associated With Response to Chemo-Immunotherapy in NSCLC: A Multi-Method Differential Abundance Analysis
R. Serna-Blasco, A. R. Festa, A. S. Martin, E. Nadal +25 more
2026Journal of Thoracic Oncology0 citations
Semantic Scholar
P2.240: Tumor BCR Repertoire Metrics Outperform PD-L1 and TMB as Survival Biomarkers in NSCLC After Adjuvant Chemoimmunotherapy
B. Sierra-Rodero, C. Martínez-Toledo, M. Molina-Alejandre, Á. Gil-González +20 more
2026Journal of Thoracic Oncology0 citations
Semantic Scholar
PT1.07.04: ARIAN, a Phase III, Randomized Study of Adjuvant Treatment With Sacituzumab and Zimberelimab in Resected Patients
V. Calvo, R. Castro, C. L. Gozálvez, D. Aguiar +29 more
2026Journal of Thoracic Oncology0 citations
Semantic Scholar
P1.199: Persistent N2 After Neoadjuvant Chemoimmunotherapy in Non-Small Cell Lung Cancer: Insights From Three Prospective Cohorts
M. Provencio, B. Massutí, V. Calvo, J. Bosch-Barrera +25 more
2026Journal of Thoracic Oncology0 citations
Semantic Scholar
P3.122: B Cell Density in Mature Tlss Is Associated With Pathological Complete Response After Neoadjuvant Chemoimmunotherapy
J. M. Gutiérrez-Escobedo, B. Sierra-Rodero, M. Molina-Alejandre, C. Martínez-Toledo +14 more
2026Journal of Thoracic Oncology0 citations
Semantic Scholar
P2.388: PALACE, Cemiplimab Trial According to ctDNA Levels: A Phase II Clinical Trial
V. Calvo, B. Massutí, A. Olivares, J. Benítez-Fuentes +14 more
2026Journal of Thoracic Oncology0 citations
Semantic Scholar
MO01.08: Association of Gut Microbiome Diversity With Survival and Immune-Related Toxicity in Locally Advanced NSCLC
A. S. M. Doblado, R. Serna-Blasco, A. Rodríguez-Festa, E. Nadal +25 more
2026Journal of Thoracic Oncology0 citations
Semantic Scholar
P3.121: Not All Residual Tumors Are Created Equal: Perioperative Chemoimmunotherapy Differentially Shapes Tumor Microenvironment
M. Molina-Alejandre, Á. Gil-González, B. Sierra-Rodero, C. Martínez-Toledo +15 more
2026Journal of Thoracic Oncology0 citations
Semantic Scholar
MA06.03 Pharmacoeconomic Analysis of NADIM 2 Trial: Cost-Effectiveness of Perioperative Chemo-Immunotherapy in Resectable Stage III NSCLC
B. Massutí, E. Nadal, J. González-Larriba, A. Martínez-Martí +15 more
2025Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
P3.01.25 Residential Radon and Molecular Alterations in Non-Small Cell Lung Cancer
V. Calvo, L. Gonzalez, L. Martín de Bernardo Gisbert, R. Serna +27 more
2025Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
P1.11.37 Impact of Immunotherapy on Overall Survival in Advanced Non-Small Cell Lung Cancer: A Real-World Evidence Analysis
E. Carcereny, M. Cobo, V. Calvo, D. Rodríguez-Abreu +27 more
2025Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
EP.06G.20 Advanced Squamous Cell Lung Carcinoma in Never Smokers: A Different Entity? Analysis from the Thoracic Tumor Registry in Spain (RTT)
M. Blanco, A. Collazo-Lorduy, M. Cobo, V. Calvo +25 more
2024Journal of Thoracic Oncology0 citations
Semantic Scholar
P3.08E.01 Perioperative Chemoimmunotherapy Rescue Cold HLA-Deficient Tumors Inducing Strong Immune Responses and Long-Term Survival
M. Molina-Alejandre, F. Perea, V. Calvo, E. Nadal +23 more
2024Journal of Thoracic Oncology0 citations
Semantic Scholar
P3.08E.04 TCR Metrics as Predictive Biomarkers of Response and Survival after Perioperative Chemoimmunotherapy. NADIM & NADIM II Trials
C. Martínez-Toledo, B. Sierra, M. Molina-Alejandre, M. Casarrubios +17 more
2024Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
EP08.03-01 Copy Number Variants and Late Somatic Mutations Underlying Tumor Progression in NADIM Clinical Trials
R. Blasco, M. Garcia Campelo, E. Nadal, P. Mediavilla +11 more
2023Journal of Thoracic Oncology0 citations
Semantic Scholar
P2.31-12 Sexual Dysfunction on Patients with Lung Cancer: Results from the CLARIFY Project
A. V. Ospina Serrano, V. Calvo, A. Collazo-Lorduy, M. Blanco +5 more
2023Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
KRAS Mutations, Potential Biomarkers for the Identification of Non-small-Cell Lung Cancer Patients That May Benefit From Immunotherapy-Based Treatments
L. Robado De Lope, R. Serna-Blasco, P. Mediavilla, V. Calvo +6 more
2023The Journal of Liquid Biopsy0 citations Open access
Semantic Scholar
P1.27-07 BRAF Mutations Identify Non-small-Cell Lung Cancer Patients Who Benefit from Neoadjuvant Chemo-Immunotherapy
L. Robado de Lope, E. Nadal, V. Calvo, J. González-Larriba +22 more
2023Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
MA03.11 Big Data and Artificial Intelligence for Exploring the Role of Genetic Risk. Family History of Cancer and Lung Cancer. Results from CLARIFY
V. Calvo, M. Vidal, E. Niazmand, E. Carcereny +16 more
2023Journal of Thoracic Oncology0 citations
Semantic Scholar
P1.22-16 ERBB3 and BRAF Mutations as Potential Biomarkers in Non-Small Cell Lung Cancer Patients Under Immunotherapy-Based Treatments
L. Robado de Lope, R. Serna-Blasco, P. Mediavilla, S. Sanz-Moreno +19 more
2023Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
MA16.04 Circulating Tumor DNA Quantification by NGS Should Be Adapted to the Methodology Used
R. Blasco, E. Nadal, V. Calvo, J. González-Larriba +25 more
2023Journal of Thoracic Oncology0 citations
Semantic Scholar
OA02.03 Tumor Bulk-RNA Seq Identifies Patients at High Risk of Progression in Non-complete Pathological Responders from NADIM Trial
M. Casarrubios, A. Cruz-Bermúdez, B. Sierra-Rodero, C. Martínez +16 more
2022Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
EP13.01-016 Are Follow-up Tests Useful in NSCLC? Experience of a Tertiary Hospital
F. Cano, Y. Díaz, V. Calvo, A. Collazo-Lorduy +10 more
2022Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
EP06.01-017 Clinical Impact of SARS-CoV2 Pandemic in the Diagnosis of Early-Stage Thoracic Tumours
Y. Díaz, M. Clemente, M. Martínez-Cutillas, M. Barturen +11 more
2022Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
EP16.02-007 Detection of Clinically Relevant Fusions and Exon Skipping Alterations in Non Small Cell Lung Cancer Patients Liquid Biopsies
E. Sánchez-Herrero, A. Giménez-Capitán, L. Robado de Lope, R. Serna-Blasco +9 more
2022Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
1168P Clinical characteristics and survival in stage I-IIIA lung cancer resected patients in Spain, analyzed in the Thoracic Tumors Registry (TTR)
Fabio Franco, E. Carcereny, R. Castro, D. Rodríguez +16 more
2021Annals of Oncology0 citations Open access
Semantic Scholar
OA14.01 Family History of Cancer and Lung Cancer: Information from the Thoracic Tumors Registry (TTR Study)
V. Calvo, E. Carcereny, D. Abreu, R. López-Castro +18 more
2021Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
P84.14 Identification of Mechanisms of Resistance to ALK Inhibitors. Next-Generation Sequencing-Based Liquid Biopsy Profiling.
E. Sánchez-Herrero, R. Serna-Blasco, V. Ivanchuk, R. Campelo +14 more
20210 citations Open access
Semantic Scholar
P84.16 Treatment Options for Patients with Brain Metastases in Oncogene-Driven Non-Small Cell Lung Cancer
Y. Garitaonaindia, M. Martínez, C. Traseira, V. Calvo +10 more
20210 citations Open access
Semantic Scholar
P66.04 Real World Data: Immunotherapy in Lung Cancer Patients over 65 Years Old in Spain
B. Núñez-García, M. Clemente, Y. Garitaonaindia, R. Noya +7 more
20210 citations Open access
Semantic Scholar
P40.12 Cardiotoxicity in Lung Cancer Patients Treated With Immune-Checkpoints Inhibitors
M. Clemente, Y. Garitaonaindia, M. Torrente, F. Franco +9 more
2021Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
1730P Cancer long survivor artificial intelligence follow-up (CLARIFY): Family history of cancer and lung cancer
V. Calvo, E. Niazmand, E. Carcereny, S. Jozashoori +16 more
2021Annals of Oncology0 citations Open access
Semantic Scholar
1786P Small cell lung cancer (SCLC) extensive stage (ES) in Spain: Efficacy of treatments, data from the thoracic tumours registry (TTR study)
E. C. Costa, V. Calvo, M. Guirado, A. L. Ortega Granados +16 more
20200 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Provencio×28
Invite
M. Provencio — researcher profile on SciRah
A. Martínez-Martí×24
Invite
A. Martínez-Martí — researcher profile on SciRah
B. Massutí×23
Invite
B. Massutí — researcher profile on SciRah
A. Insa×21
Invite
A. Insa — researcher profile on SciRah

J. Bosch-Barrera

×20

Invite

J. Bosch-Barrera — researcher profile on SciRah

Invite

M. Cobo — researcher profile on SciRah

M. Provencio×19

Invite

M. Provencio — researcher profile on SciRah

D. Rodríguez-Abreu×18

Invite

D. Rodríguez-Abreu — researcher profile on SciRah

Invite

E. Nadal — researcher profile on SciRah

Invite

A. Romero — researcher profile on SciRah

Invite

R. Bernabe — researcher profile on SciRah

J. D. De Castro×15

Invite

J. D. De Castro — researcher profile on SciRah